Minimal residual disease (mrd) in multiple myeloma: prognostic and therapeutic implications (including imaging)
1St James's Institute of Oncology, Leeds, United Kingdom.
Hemasphere
|March 21, 2022
Abstract
No abstract available in PubMed .
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
